Long-lasting anti-platelet activity of cilostazol from poly(ε-caprolactone)-poly(ethylene glycol) blend nanocapsules

35Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Cilostazol (CLZ) acts as a vasodilator and antiplatelet agent and is the main drug for the treatment of intermittent claudication (IC) related to peripheral arterial disease (PAD). The usual oral dose is 100 mg twice a day, which represents a disadvantage in treatment compliance. CLZ presents several side effects, such as headache, runny nose, and dizziness. This paper aimed to obtain novel polymeric nanocapsules prepared from poly(ε-caprolactone)-poly(ethylene glycol) (PCL-PEG) blend containing CLZ. Nanocapsules showed pH values between 6.1 and 6.3, average size lower than 137 nm, low polydispersity index (<0.22) and negative zeta potential. These nanoformulations demonstrated spherical shape with smooth surface. Results achieved by X-ray diffraction (XRD) and differential scanning calorimetry (DSC) indicated drug amorphization compared to pure CLZ. Fourier-transformed infrared spectroscopy (FTIR) showed no chemical bonds between drug and polymers. Formulations presented suitable stability for physical parameters. The in vitro drug release demonstrated prolonged release with no burst effect. Drug release was controlled by both mechanisms of polymer relaxation/degradation and Fickian diffusion. Moreover, chosen CLZ-loaded nanocapsules provided an in vivo prolonged antiplatelet effect for CLZ statistically similar to aspirin. These formulations can be further used as a feasible oral drug delivery carrier for controlled release of CLZ in order to treat PAD and IC events.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Gomes, M. L. S., da Silva Nascimento, N., Borsato, D. M., Pretes, A. P., Nadal, J. M., Novatski, A., … Zanin, S. M. W. (2019). Long-lasting anti-platelet activity of cilostazol from poly(ε-caprolactone)-poly(ethylene glycol) blend nanocapsules. Materials Science and Engineering C, 94, 694–702. https://doi.org/10.1016/j.msec.2018.10.029

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 14

74%

Professor / Associate Prof. 3

16%

Researcher 2

11%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 11

61%

Biochemistry, Genetics and Molecular Bi... 3

17%

Chemical Engineering 2

11%

Agricultural and Biological Sciences 2

11%

Save time finding and organizing research with Mendeley

Sign up for free